251 related articles for article (PubMed ID: 36717478)
21. Polyglutamine-Expanded Androgen Receptor Alteration of Skeletal Muscle Homeostasis and Myonuclear Aggregation Are Affected by Sex, Age and Muscle Metabolism.
Chivet M; Marchioretti C; Pirazzini M; Piol D; Scaramuzzino C; Polanco MJ; Romanello V; Zuccaro E; Parodi S; D'Antonio M; Rinaldi C; Sambataro F; Pegoraro E; Soraru G; Pandey UB; Sandri M; Basso M; Pennuto M
Cells; 2020 Jan; 9(2):. PubMed ID: 32019272
[TBL] [Abstract][Full Text] [Related]
22. Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy.
Montie HL; Cho MS; Holder L; Liu Y; Tsvetkov AS; Finkbeiner S; Merry DE
Hum Mol Genet; 2009 Jun; 18(11):1937-50. PubMed ID: 19279159
[TBL] [Abstract][Full Text] [Related]
23. The Role of the Protein Quality Control System in SBMA.
Rusmini P; Crippa V; Cristofani R; Rinaldi C; Cicardi ME; Galbiati M; Carra S; Malik B; Greensmith L; Poletti A
J Mol Neurosci; 2016 Mar; 58(3):348-64. PubMed ID: 26572535
[TBL] [Abstract][Full Text] [Related]
24. Autophagic and Proteasomal Mediated Removal of Mutant Androgen Receptor in Muscle Models of Spinal and Bulbar Muscular Atrophy.
Cicardi ME; Cristofani R; Crippa V; Ferrari V; Tedesco B; Casarotto E; Chierichetti M; Galbiati M; Piccolella M; Messi E; Carra S; Pennuto M; Rusmini P; Poletti A
Front Endocrinol (Lausanne); 2019; 10():569. PubMed ID: 31481932
[TBL] [Abstract][Full Text] [Related]
25. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy.
Adachi H; Waza M; Katsuno M; Tanaka F; Doyu M; Sobue G
Neuropathol Appl Neurobiol; 2007 Apr; 33(2):135-51. PubMed ID: 17359355
[TBL] [Abstract][Full Text] [Related]
26. Heat shock protein 70 chaperone overexpression ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model by reducing nuclear-localized mutant androgen receptor protein.
Adachi H; Katsuno M; Minamiyama M; Sang C; Pagoulatos G; Angelidis C; Kusakabe M; Yoshiki A; Kobayashi Y; Doyu M; Sobue G
J Neurosci; 2003 Mar; 23(6):2203-11. PubMed ID: 12657679
[TBL] [Abstract][Full Text] [Related]
27. Molecular Mechanisms and Therapeutics for SBMA/Kennedy's Disease.
Arnold FJ; Merry DE
Neurotherapeutics; 2019 Oct; 16(4):928-947. PubMed ID: 31686397
[TBL] [Abstract][Full Text] [Related]
28. [Disease-modifying therapy for spinal and bulbar muscular atrophy (SBMA)].
Suzuki K; Banno H; Katsuno M; Adachi H; Tanaka F; Sobue G
Brain Nerve; 2012 Mar; 64(3):237-44. PubMed ID: 22402717
[TBL] [Abstract][Full Text] [Related]
29. CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model.
Adachi H; Waza M; Tokui K; Katsuno M; Minamiyama M; Tanaka F; Doyu M; Sobue G
J Neurosci; 2007 May; 27(19):5115-26. PubMed ID: 17494697
[TBL] [Abstract][Full Text] [Related]
30. Spinal and bulbar muscular atrophy: From molecular pathogenesis to pharmacological intervention targeting skeletal muscle.
Marchioretti C; Andreotti R; Zuccaro E; Lieberman AP; Basso M; Pennuto M
Curr Opin Pharmacol; 2023 Aug; 71():102394. PubMed ID: 37463556
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional activation of TFEB/ZKSCAN3 target genes underlies enhanced autophagy in spinobulbar muscular atrophy.
Chua JP; Reddy SL; Merry DE; Adachi H; Katsuno M; Sobue G; Robins DM; Lieberman AP
Hum Mol Genet; 2014 Mar; 23(5):1376-86. PubMed ID: 24150846
[TBL] [Abstract][Full Text] [Related]
32. Spinal and bulbar muscular atrophy.
Lieberman AP
Handb Clin Neurol; 2018; 148():625-632. PubMed ID: 29478604
[TBL] [Abstract][Full Text] [Related]
33. Prenatal flutamide enhances survival in a myogenic mouse model of spinal bulbar muscular atrophy.
Johansen JA; Troxell-Smith SM; Yu Z; Mo K; Monks DA; Lieberman AP; Breedlove SM; Jordan CL
Neurodegener Dis; 2011; 8(1-2):25-34. PubMed ID: 20689246
[TBL] [Abstract][Full Text] [Related]
34. Role of androgen receptor polyQ chain elongation in Kennedy's disease and use of natural osmolytes as potential therapeutic targets.
Kumar R
IUBMB Life; 2012 Nov; 64(11):879-84. PubMed ID: 23024039
[TBL] [Abstract][Full Text] [Related]
35. Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy.
Cortes CJ; Ling SC; Guo LT; Hung G; Tsunemi T; Ly L; Tokunaga S; Lopez E; Sopher BL; Bennett CF; Shelton GD; Cleveland DW; La Spada AR
Neuron; 2014 Apr; 82(2):295-307. PubMed ID: 24742458
[TBL] [Abstract][Full Text] [Related]
36. Exploring the Role of Posttranslational Modifications in Spinal and Bulbar Muscular Atrophy.
Gogia N; Ni L; Olmos V; Haidery F; Luttik K; Lim J
Front Mol Neurosci; 2022; 15():931301. PubMed ID: 35726299
[TBL] [Abstract][Full Text] [Related]
37. Molecular pathophysiology and disease-modifying therapies for spinal and bulbar muscular atrophy.
Katsuno M; Banno H; Suzuki K; Adachi H; Tanaka F; Sobue G
Arch Neurol; 2012 Apr; 69(4):436-40. PubMed ID: 22158719
[TBL] [Abstract][Full Text] [Related]
38. Rescue of Metabolic Alterations in AR113Q Skeletal Muscle by Peripheral Androgen Receptor Gene Silencing.
Giorgetti E; Yu Z; Chua JP; Shimamura R; Zhao L; Zhu F; Venneti S; Pennuto M; Guan Y; Hung G; Lieberman AP
Cell Rep; 2016 Sep; 17(1):125-136. PubMed ID: 27681426
[TBL] [Abstract][Full Text] [Related]
39. [Study of androgen receptor expression and neuronal vulnerability in X-linked spinal and bulbar muscular atrophy].
Matsuura T
Hokkaido Igaku Zasshi; 1996 Nov; 71(6):785-99. PubMed ID: 8996845
[TBL] [Abstract][Full Text] [Related]
40. Deubiquitinase USP7 contributes to the pathogenicity of spinal and bulbar muscular atrophy.
Pluciennik A; Liu Y; Molotsky E; Marsh GB; Ranxhi B; Arnold FJ; St-Cyr S; Davidson B; Pourshafie N; Lieberman AP; Gu W; Todi SV; Merry DE
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33170804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
